About Benign Prostatic Hyperplasia DeviceBenign prostatic hyperplasia is a condition characterized by non-cancerous proliferation of prostate gland cells. This causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. It is associated with aging, hormone imbalances, and abnormal cell growth. Benign prostatic hyperplasia device is used to perform invasive and MI surgeries to remedy a blocked urethra.
Technavio's analysts forecast the global benign prostatic hyperplasia devices market to grow at a CAGR of 5.05% percent over the period 2014-2019.
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/59112-global-benign-prostatic-hyperplasia-devices-market-2015-2019
Covered in this ReportThis report covers the present scenario and growth prospects of the global benign prostatic hyperplasia devices market for the period 2014-2019. The global benign prostatic hyperplasia devices market is divided into six segments based on procedure type: TURP, TUMT, TUNA, laser surgery, prostatic stenting, and others (water-induced thermotherapy, high-intensity frequency ultrasound, and open prostatectomy).
Technavio's report, Global Benign Prostatic Hyperplasia Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the global benign prostatic hyperplasia devices market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions• Americas
• APAC
• EMEA
Key Vendors• Endo Health Solutions
• Karl Storz
• Lumenis
• Olympus
• Urologix
Other Prominent Vendors• Boston Scientific
• Coloplast
• Lisa Laser
• Medi-tate
• Medifocus
• Neotract
• ProArc Medical
• UroTech
Market Driver• Growing Elderly Population
• For a full, detailed list, view our report
Market Challenge• Alternative Treatment Methods
• For a full, detailed list, view our report
Market Trend• High Number of Outpatient Procedures
• For a full, detailed list, view our report
Key Questions Answered in this Report• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Complete Report Details @ https://www.wiseguyreports.com/reports/59112-global-benign-prostatic-hyperplasia-devices-market-2015-2019
Table of Contents
- Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market overview
03.2 Product offerings
04. Market Research Methodology
04.1 Market research process
04.2 Research methodology
05. Introduction
06. Market Landscape
06.1 Market overview
06.2 Market size and forecast
06.3 Five forces analysis
07. Benign Prostatic Hyperplasia: An Overview
07.1 Incidence and prevalence
07.2 Major symptoms
08. Market Segmentation by Procedure
08.1 TURP
08.2 Laser surgery
08.3 TUMT
08.4 TUNA
08.5 Prostatic stenting
08.6 Others
09. Geographical Segmentation
09.1 Benign prostatic hyperplasia devices market in Americas
09.1.1 Market size and forecast
09.2 Benign prostatic hyperplasia devices market in EMEA
09.2.1 Market size and forecast
09.3 Benign prostatic hyperplasia devices market in APAC
09.3.1 Market size and forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and Their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and Their Impact
17. Vendor Landscape
17.1 Competitive scenario
17.1.1 Key news
17.2 Vendor analysis 2014
17.3 Other prominent vendors
18. Key Vendor Analysis
18.1 Endo International18.1.1 Key facts
18.1.2 Business overview
18.1.3 Business segmentation by revenue 2013
18.1.4 Business segmentation by revenue 2012 and 2013
18.1.5 Geographical segmentation by revenue 2013
18.1.6 Business strategy
18.1.7 Recent developments
18.1.8 SWOT analysis
18.2 Karl Storz18.2.1 Key facts
18.2.2 Business overview
18.2.3 Business segmentation
18.2.4 Business strategy
18.2.5 Key developments
18.2.6 SWOT analysis
18.3 Lumenis18.3.1 Key facts
18.3.2 Business overview
18.3.3 Business segmentation by revenue 2013
18.3.4 Business segmentation by revenue 2012 and 2013
18.3.5 Geographical segmentation by revenue 2013
18.3.6 Business strategy
18.3.7 Recent developments
18.3.8 SWOT analysis
18.4 Olympus18.4.1 Key facts
18.4.2 Business overview
18.4.3 Business segmentation by revenue 2013
18.4.4 Sales by geography
18.4.5 Business strategy
18.4.6 Key developments
18.4.7 SWOT analysis
18.5 Urologix18.5.1 Key facts
18.5.2 Business overview
18.5.3 Business strategy
18.5.4 SWOT analysis
19. Other Reports in This Series
Continued…….
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
No comments:
Post a Comment